STAT+: Pharmalittle: We’re reading about Sanofi settling an EU antitrust probe, ‘pharma bro’ Shkreli, and more

Loading TBN…

Briefings

The U.S. Federal Trade Commission and seven states have sought contempt sanctions against Martin Shkreli for violating a court order banning his work in the pharmaceutical industry. Shkreli, known as 'pharma bro,' was sentenced to seven years in 2018 for defrauding investors and was banned from working in the industry since 2022. Meanwhile, the European Union antitrust regulators accepted concessions from Sanofi to settle an investigation into an allegedly misleading campaign disparaging the Fluad vaccine, avoiding a potential fine.

Key points

The U.S. Federal Trade Commission and seven states are seeking contempt sanctions against Martin Shkreli for violating a court order banning him from working in the pharmaceutical industry.

Sanofi accepted EU antitrust concessions to settle an investigation into an allegedly misleading campaign disparaging the Fluad vaccine, avoiding a potential fine.

Context

Martin Shkreli, known as 'pharma bro,' was sentenced to seven years in 2018 for defrauding investors and was banned from working in the industry since 2022. The European Commission suggested Sanofi portrayed the Fluad vaccine as inferior to its own Efluelda vaccine in a campaign targeting health care professionals in Germany and France.

Limitations

The evidence is limited to a single article snippet from October 2026. It does not provide details on the specific nature of the EU investigation, the exact timeline of the Sanofi settlement, or the specific consequences of the U.S. contempt sanctions beyond the stated sentence.

Generated by Bittrees-hosted qwen35-2b sha256:aaf42c8b7c3c on 24/10/2026, 10:09:51 UTC. Based on publisher-provided feed evidence; may not cover the full original article. Check the source for details.

View archived briefing on IPFS
bafybeichwueh3urwxtqav6koepu4xwrswxc2wa7qnpgwqeb2ejykvuomsa